The sales moved down -38.61% to Rs. 2910.00 millions for the March 2023 quarter as compared to Rs. 4740.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2023 is Rs. -2990.00 millions as compared to Net Profit of Rs. 400.00 millions of corresponding quarter ended March 2022Operating profit Margin for the quarter ended March 2023 slipped to -10.00% as compared to 2080.00% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 2910.00 4740.00 -38.61 10720.00 13720.00 -21.87 10720.00 13720.00 -21.87
Other Income 290.00 220.00 31.82 670.00 380.00 76.32 670.00 380.00 76.32
PBIDT -10.00 2080.00 -100.48 1370.00 2600.00 -47.31 1370.00 2600.00 -47.31
Interest 580.00 780.00 -25.64 2290.00 2730.00 -16.12 2290.00 2730.00 -16.12
PBDT -2440.00 1300.00 -287.69 -3270.00 -130.00 2415.38 -3270.00 -130.00 2415.38
Depreciation 450.00 430.00 4.65 1860.00 1710.00 8.77 1860.00 1710.00 8.77
PBT -2890.00 870.00 -432.18 -5130.00 -1840.00 178.80 -5130.00 -1840.00 178.80
TAX 100.00 470.00 -78.72 -470.00 -440.00 6.82 -470.00 -440.00 6.82
Deferred Tax 100.00 420.00 -76.19 -470.00 -490.00 -4.08 -470.00 -490.00 -4.08
PAT -2990.00 400.00 -847.50 -4660.00 -1400.00 232.86 -4660.00 -1400.00 232.86
Equity 720.00 720.00 0.00 720.00 720.00 0.00 720.00 720.00 0.00
PBIDTM(%) -0.34 43.88 -100.78 12.78 18.95 -32.56 12.78 18.95 -32.56

Wockhardt Share Price

1461.15 -28.45 (-1.91%)
26-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.50
Dr. Reddys Lab 1355.15
Cipla 1489.20
Lupin 2181.60
Zydus Lifesciences 959.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.